OBI Pharma, Inc. (TPEX:4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.95
+0.75 (2.40%)
Aug 15, 2025, 1:30 PM CST

OBI Pharma Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-2,412-2,310-1,046-1,614-1,531-1,378
Upgrade
Depreciation & Amortization
228.13216.82244.86240.92208.75214.53
Upgrade
Other Amortization
5.445.444.15.697.5217.31
Upgrade
Loss (Gain) From Sale of Assets
0.06-43.720.39-0.0115.08-
Upgrade
Asset Writedown & Restructuring Costs
--5.96---
Upgrade
Loss (Gain) From Sale of Investments
0.23-0.26-879.321.02-0.37-54
Upgrade
Loss (Gain) on Equity Investments
192.26233.18163.58---
Upgrade
Stock-Based Compensation
49.4463.98119.214954.0276.82
Upgrade
Other Operating Activities
-175.13-174.04-201.73-310.03-195.51-98.03
Upgrade
Change in Accounts Receivable
-1.872.28-4.441.43-2.010.07
Upgrade
Change in Inventory
6.14-1.79-3.96-9.74-2.2-3.16
Upgrade
Change in Accounts Payable
0.272.13-0.370.620.37-0.02
Upgrade
Change in Unearned Revenue
-7.831.53.133.16--77.64
Upgrade
Change in Other Net Operating Assets
136.71171.01-57.89-87.84-1.5720.75
Upgrade
Operating Cash Flow
-1,975-1,834-1,653-1,620-1,064-1,609
Upgrade
Capital Expenditures
-60.59-113.24-101.93-254.65-241.33-182.68
Upgrade
Sale of Property, Plant & Equipment
-144.630.20.05--
Upgrade
Cash Acquisitions
----472.65-
Upgrade
Divestitures
--30.41-564.08---
Upgrade
Sale (Purchase) of Intangibles
-6.39-6.32-6.23-45.91-3.86-2.96
Upgrade
Investment in Securities
-119.7481.13-2,110109.29-140-
Upgrade
Other Investing Activities
-9.917.23-13.1721.33-4.79-10.26
Upgrade
Investing Cash Flow
-196.58483.02-2,795-169.8982.68-195.9
Upgrade
Short-Term Debt Issued
-0.41-15.71-9.47
Upgrade
Long-Term Debt Issued
-100----
Upgrade
Total Debt Issued
124.66100.41-15.71-9.47
Upgrade
Short-Term Debt Repaid
--4.31-11.4--9.47-
Upgrade
Long-Term Debt Repaid
--84.44-51.61-59.31-58.07-54.6
Upgrade
Total Debt Repaid
-95.35-88.74-63.01-59.31-67.54-54.6
Upgrade
Net Debt Issued (Repaid)
29.3111.67-63.01-43.61-67.54-45.13
Upgrade
Issuance of Common Stock
2,1642,16317.613,15016.9922.94
Upgrade
Other Financing Activities
--0652.47903.59214.3305.29
Upgrade
Financing Cash Flow
2,1932,175607.074,010163.75283.09
Upgrade
Foreign Exchange Rate Adjustments
-11.98.4-0.568.53-8.060.54
Upgrade
Net Cash Flow
9.13832.77-3,8422,229-826.12-1,522
Upgrade
Free Cash Flow
-2,036-1,947-1,755-1,874-1,306-1,792
Upgrade
Free Cash Flow Margin
-3297.29%-3105.95%-4223.71%-39786.71%-6956.13%-1272.04%
Upgrade
Free Cash Flow Per Share
-8.13-8.33-7.66-8.44-6.56-9.02
Upgrade
Cash Interest Paid
12.3114.653.743.993.84.18
Upgrade
Cash Income Tax Paid
--12.38-7.28-9.56-15.154.39
Upgrade
Levered Free Cash Flow
-1,184-1,028-1,228-1,406-1,002-770.41
Upgrade
Unlevered Free Cash Flow
-1,176-1,021-1,223-1,403-999.39-767.8
Upgrade
Change in Working Capital
133.41175.12-63.54-92.37376.71-388.14
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.